UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 82

Sortiert nach

FTO downregulation mediated by hypoxia facilitates colorectal cancer metastasis

Oncogene, 2021-08, Vol.40 (33), p.5168-5181

2021

Volltextzugriff (PDF)

Identification of MicroRNA‐214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression

Hepatology (Baltimore, Md.), 2014-08, Vol.60 (2), p.598-609

2014

Volltextzugriff (PDF)

Modulation of Redox Homeostasis by Inhibition of MTHFD2 in Colorectal Cancer: Mechanisms and Therapeutic Implications

JNCI : Journal of the National Cancer Institute, 2019-06, Vol.111 (6), p.584-596

2019

Volltextzugriff (PDF)

Genomic temporal heterogeneity of circulating tumour DNA in unresectable metastatic colorectal cancer under first-line treatment

Gut, 2022-07, Vol.71 (7), p.1340

2022

Volltextzugriff (PDF)

Fibrinogen promotes malignant biological tumor behavior involving epithelial–mesenchymal transition via the p-AKT/p-mTOR pathway in esophageal squamous cell carcinoma

Journal of cancer research and clinical oncology, 2017-12, Vol.143 (12), p.2413-2424

2017

Volltextzugriff (PDF)

ABO blood group, hepatitis B viral infection and risk of pancreatic cancer

International journal of cancer, 2012-07, Vol.131 (2), p.461-468

2012

Volltextzugriff (PDF)

Recombinant human endostatin plus paclitaxel/nedaplatin for recurrent or metastatic advanced esophageal squamous cell carcinoma: a prospective, single-arm, open-label, phase II study

Investigational new drugs, 2021-04, Vol.39 (2), p.516-523

2021

Volltextzugriff (PDF)

Frequency and clinicopathological features of metastasis to liver, lung, bone, and brain from gastric cancer: A SEER‐based study

Cancer medicine (Malden, MA), 2018-08, Vol.7 (8), p.3662-3672

2018

Volltextzugriff (PDF)

Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer

Carcinogenesis (New York), 2013-04, Vol.34 (4), p.803-811

2013

Volltextzugriff (PDF)

The efficacy and safety of modified FOLFIRINOX as first‐line chemotherapy for Chinese patients with metastatic pancreatic cancer

Cancer communications (London, England), 2019-05, Vol.39 (1), p.1-8

2019

Volltextzugriff (PDF)

Efficacy and safety of modified FOLFIRINOX as salvage therapy for patients with refractory advanced biliary tract cancer: a retrospective study

Investigational new drugs, 2021-06, Vol.39 (3), p.836-845

2021

Volltextzugriff (PDF)

Right‐ and left‐sided colorectal cancers respond differently to cetuximab

Ai zheng, 2015-06, Vol.34 (3), p.1-10, Article 24

2015

Volltextzugriff (PDF)

HER2‐positive patients receiving trastuzumab treatment have a comparable prognosis with HER2‐negative advanced gastric cancer patients: A prospective cohort observation

International journal of cancer, 2014-05, Vol.134 (10), p.2468-2477

2014

Volltextzugriff (PDF)

Expert opinions on immunotherapy for patients with colorectal cancer

Cancer communications (London, England), 2020-10, Vol.40 (10), p.467-472

2020

Volltextzugriff (PDF)

Phase III randomized, placebo‐controlled, double‐blind study of monosialotetrahexosylganglioside for the prevention of oxaliplatin‐induced peripheral neurotoxicity in stage II/III colorectal cancer

Cancer medicine (Malden, MA), 2020-01, Vol.9 (1), p.151-159

2020

Volltextzugriff (PDF)

Correlation between immune signature and high‐density lipoprotein cholesterol level in stage II/III colorectal cancer

Cancer medicine (Malden, MA), 2019-03, Vol.8 (3), p.1209-1217

2019

Volltextzugriff (PDF)

A novel prognostic nomogram for colorectal cancer liver metastasis patients with recurrence after hepatectomy

Cancer medicine (Malden, MA), 2021-03, Vol.10 (5), p.1535-1544

2021

Volltextzugriff (PDF)

Glucose metabolism inhibitor PFK-015 combined with immune checkpoint inhibitor is an effective treatment regimen in cancer

Oncoimmunology, 2022, Vol.11 (1), p.2079182-2079182

2022

Volltextzugriff (PDF)

The prognostic value of preoperative serum lactate dehydrogenase levels in patients underwent curative‐intent hepatectomy for colorectal liver metastases: A two‐center cohort study

Cancer medicine (Malden, MA), 2021-11, Vol.10 (22), p.8005-8019

2021

Volltextzugriff (PDF)

Effect of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Women: A Randomized Clinical Trial

JAMA network open, 2021-04, Vol.4 (4), p.e215250-e215250

2021

Volltextzugriff (PDF)

Prognostic relevance of BRD7 expression in colorectal carcinoma

European journal of clinical investigation, 2013-02, Vol.43 (2), p.131-140

2013

Volltextzugriff (PDF)

A 3-Year Survival Update from a Phase 2 Study of Paclitaxel Plus Cisplatin and 5-Fuorouracil Induction Chemotherapy for Locally Advanced Borderline-Resectable Esophageal Squamous Cell Carcinoma: The NEOCRTEC-1601 Clinical Trial

Annals of surgical oncology, 2024-02, Vol.31 (2), p.838-846

2024

Volltextzugriff (PDF)

Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer

Medical oncology (Northwood, London, England), 2012-12, Vol.29 (5), p.3092-3100

2012

Volltextzugriff (PDF)

ASO Visual Abstract: A 3-Year Survival Update From a Phase II Study of Paclitaxel Plus Cisplatin and 5-Fluorouracil Induction Chemotherapy for Locally Advanced Borderline-Resectable Esophageal Squamous Cell Carcinoma: The NEOCRTEC-1601 Clinical Trial

Annals of surgical oncology, 2024-04, Vol.31 (4), p.2527-2528

2024

Volltextzugriff (PDF)

Cellular mechanisms of the cytotoxicity of the anticancer drug elesclomol and its complex with Cu(II)

Biochemical pharmacology, 2015-02, Vol.93 (3), p.266-276

2015

Volltextzugriff (PDF)

1 – 25 von 82

Suche als RSS-Feed

Aktive Filter

KollektionJournals@Ovid Full Text

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(78)

Publikationsform

Artikel
(82)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

FTO downregulation mediated by hypoxia facilitates colorectal cancer metastasis

Identification of MicroRNA‐214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression

Modulation of Redox Homeostasis by Inhibition of MTHFD2 in Colorectal Cancer: Mechanisms and Therapeutic Implications

Genomic temporal heterogeneity of circulating tumour DNA in unresectable metastatic colorectal cancer under first-line treatment

Fibrinogen promotes malignant biological tumor behavior involving epithelial–mesenchymal transition via the p-AKT/p-mTOR pathway in esophageal squamous cell carcinoma

ABO blood group, hepatitis B viral infection and risk of pancreatic cancer

Recombinant human endostatin plus paclitaxel/nedaplatin for recurrent or metastatic advanced esophageal squamous cell carcinoma: a prospective, single-arm, open-label, phase II study

Frequency and clinicopathological features of metastasis to liver, lung, bone, and brain from gastric cancer: A SEER‐based study

Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer

The efficacy and safety of modified FOLFIRINOX as first‐line chemotherapy for Chinese patients with metastatic pancreatic cancer

Efficacy and safety of modified FOLFIRINOX as salvage therapy for patients with refractory advanced biliary tract cancer: a retrospective study

Right‐ and left‐sided colorectal cancers respond differently to cetuximab

HER2‐positive patients receiving trastuzumab treatment have a comparable prognosis with HER2‐negative advanced gastric cancer patients: A prospective cohort observation

Expert opinions on immunotherapy for patients with colorectal cancer

Phase III randomized, placebo‐controlled, double‐blind study of monosialotetrahexosylganglioside for the prevention of oxaliplatin‐induced peripheral neurotoxicity in stage II/III colorectal cancer

Correlation between immune signature and high‐density lipoprotein cholesterol level in stage II/III colorectal cancer

A novel prognostic nomogram for colorectal cancer liver metastasis patients with recurrence after hepatectomy

Glucose metabolism inhibitor PFK-015 combined with immune checkpoint inhibitor is an effective treatment regimen in cancer

The prognostic value of preoperative serum lactate dehydrogenase levels in patients underwent curative‐intent hepatectomy for colorectal liver metastases: A two‐center cohort study

Effect of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Women: A Randomized Clinical Trial

Prognostic relevance of BRD7 expression in colorectal carcinoma

A 3-Year Survival Update from a Phase 2 Study of Paclitaxel Plus Cisplatin and 5-Fuorouracil Induction Chemotherapy for Locally Advanced Borderline-Resectable Esophageal Squamous Cell Carcinoma: The NEOCRTEC-1601 Clinical Trial

Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer

ASO Visual Abstract: A 3-Year Survival Update From a Phase II Study of Paclitaxel Plus Cisplatin and 5-Fluorouracil Induction Chemotherapy for Locally Advanced Borderline-Resectable Esophageal Squamous Cell Carcinoma: The NEOCRTEC-1601 Clinical Trial

Cellular mechanisms of the cytotoxicity of the anticancer drug elesclomol and its complex with Cu(II)

Aktive Filter

Suchergebnisse filtern